Iveric Bio to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Wednesday, March 3, 2021

Rhea-AI Summary

IVERIC bio, Inc. (Nasdaq: ISEE) will announce its fourth quarter and full year 2020 financial results on March 3, 2021. Following the release, the management team will host a live conference call at 8:00 a.m. ET to discuss the financial outcomes and general business updates. Investors can access the call by dialing 888-221-3881 (USA) or 323-794-2590 (International) with passcode 9597743. The call will also be available via webcast on the IVERIC bio website.

The company focuses on developing treatments for retinal diseases, highlighting its commitment to addressing significant unmet medical needs.

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its fourth quarter and full year 2020 financial and operating results on Wednesday, March 3, 2021. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide a general business update.

To participate in this conference call, dial 888-221-3881 (USA) or 323-794-2590 (International), passcode 9597743. A live, listen-only audio webcast of the conference call can be accessed on the Investors section of the Iveric Bio website at www.ivericbio.com. A replay will be available approximately two hours following the live call for two weeks. The replay number is 888-203-1112 (USA Toll Free), passcode 9597743.

About Iveric Bio

Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. Vision is Our Mission. For more information on the Company, please visit www.ivericbio.com.

Forward-looking Statements

Any statements in this press release about Iveric Bio’s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Any forward-looking statements represent Iveric Bio’s views only as of the date of this press release. Iveric Bio anticipates that subsequent events and developments will cause its views to change. While Iveric Bio may elect to update these forward-looking statements at some point in the future, Iveric Bio specifically disclaims any obligation to do so.

ISEE-G

View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005252/en/

FAQ

When will IVERIC bio announce its Q4 and full year 2020 financial results?

IVERIC bio will announce its financial results on March 3, 2021.

What time is the IVERIC bio conference call scheduled?

The conference call is scheduled for 8:00 a.m. Eastern Time.

How can investors participate in the IVERIC bio conference call?

Investors can participate by dialing 888-221-3881 (USA) or 323-794-2590 (International) with passcode 9597743.

Where can I access the IVERIC bio conference call webcast?

The webcast can be accessed on the Investors section of the IVERIC bio website.

What is the focus of IVERIC bio's development efforts?

IVERIC bio focuses on the discovery and development of novel treatments for retinal diseases.